Inventor · disambiguated record
Ernesto Isaac Wasserman
Also filed as: WASSERMAN ERNESTO ISAAC
2 granted patents·8 pending applications·2 citations·filing 2019–2023
40Inventor score
Files withMERUS NV10
Top patents by PatentIndex Score
10 records- 0178US11873338B2CLEC12AxCD3 bispecific antibodies and methods for the treatment of diseaseMERUS NV·Filed 2019·Granted Jan 16, 2024·2 cites·13 claims
- 0269US12503509B2CLEC12AxCD3 bispecific antibodies and methods for the treatment of diseaseMERUS NV·Filed 2023·Granted Dec 23, 2025·0 cites·27 claims
- 0350US2025051849A1Liquid biopsy assays for detecting nrg1 fusion polynucleotidesMERUS NV·Filed 2022·Application pending·0 cites
- 0450US2024425604A1Treatment of immune checkpoint inhibitor-treated cancers with high egfr expression using an antibody that binds at least egfrMERUS NV·Filed 2022·Application pending·0 cites
- 0550US2025305053A1New nrg1 fusions, fusion junctions and methods for detecting themMERUS NV·Filed 2022·Application pending·0 cites
- 0649US2024052050A1Multispecific antibodies for the treatment of cancerMERUS NV·Filed 2021·Application pending·0 cites
- 0747US2024336689A1Treatment of cancers with an antibody that binds lgr5 and egfrMERUS NV·Filed 2021·Application pending·0 cites
- 0846US2024026029A1Means and methods for treating subjects with erbb3 mutation positive cancerMERUS NV·Filed 2021·Application pending·0 cites
- 0944US2023192866A1Treatment of cancers with an antibody that binds lgr5 and egfrMERUS NV·Filed 2021·Application pending·0 cites
- 1042US2022372166A1Means and methods for treating subjects with her2 and her3 positive cancerMERUS NV·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ernesto Isaac Wasserman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →